New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.
about
HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in miceWnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2VEGF-Trap: a VEGF blocker with potent antitumor effects.Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vesselsA Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end pointsExpression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors.Antiangiogenic mechanisms and factors in breast cancer treatmentVon Willebrand factor, angiodysplasia and angiogenesisProfile of trebananib (AMG386) and its potential in the treatment of ovarian cancerIntegrative models of vascular remodeling during tumor growthIn vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide regionThe transcription factor Net regulates the angiogenic switchVascular endothelial growth factor and angiopoietins regulate sinusoidal regeneration and remodeling after partial hepatectomy in ratsERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expressionSickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In VivoImaging hemodynamics.Computer simulation of glioma growth and morphology.Mathematical models of the VEGF receptor and its role in cancer therapy.Multiscale modelling and nonlinear simulation of vascular tumour growth.Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy responseUpregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer.Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling.Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatmentCalycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVECExpression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease.Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivoExpression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.Angiogenesis: Future of pharmacological modulation.Combination therapy in combating cancer.Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice.Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma.Nonlinear modelling of cancer: bridging the gap between cells and tumoursAngiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.Delivery of lipoplexes for genotherapy of solid tumours: role of vascular endothelial cells.Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research.
P2860
Q21131825-A6D82DB5-2E5D-4472-BDA5-EF8CF52660F6Q24306687-C2FA8DEC-A518-4B30-ABF5-C8F206B61DE3Q24535043-0C19DBCC-D31A-48FA-AD6C-7EB1883F505DQ24644150-2408A666-0356-4108-A8BC-2BFAFD67C45FQ24651047-4F3F3D4F-0003-4DF1-99A1-91EEDC7E703AQ24803501-DE532AF1-BD4C-4428-B9E1-CEEE56DAF0D3Q26751226-B2850CC6-143D-4906-9ECC-FE9FE14B9ABDQ26852889-A71863BE-85EC-449C-9529-38F41E0CD868Q26991997-317353F3-96DC-44BA-BE0A-A6762448E62EQ27025653-16195D8D-8139-47B6-9874-CFFDE24E8B12Q27342927-A43B26DC-7E4D-4B08-8884-B3B86F0DB74EQ28205770-5BAF1F75-DD2E-45DF-A728-F694FFF59C22Q28504967-BC731A34-D877-43E2-97FB-65EBEAA54711Q28570010-D03970C2-0D99-49A1-9E0A-8D7EAFA6D9CFQ28591302-F078ADF7-1243-4ECB-9635-D1EDD5597689Q28596621-21DC9E01-EC80-45CD-B1CE-9A5EB2523AECQ30439974-14091102-DBD2-4435-BDC1-348CBDB7CFF6Q30481298-111377B6-C06F-40DF-8146-F314BC130DB6Q30481811-31BFD6B4-1608-44EA-BC4E-A0CB5FE99DD7Q30498144-4E291B4D-6BC6-4EBE-AD1D-84CABADAB4AFQ30573416-416B3B5F-88FE-4CBB-AFF8-13529566BBDCQ30724325-EEE9FC23-417B-459A-A6BB-49F969FFAC49Q31043193-C9C37A62-3014-4270-85BD-8641BB7AFFFFQ31121875-F6011706-13CC-49F0-B957-EACD47A5429AQ33209039-E00AA82D-C87C-4CB9-B7A8-E41B354BB362Q33217407-1EE2C4F4-290D-425A-A82F-548E237C5CFEQ33649600-7BA1D188-4733-44A0-80FB-6D40F0ACE782Q33769685-07D7C29E-2BA5-4494-99E5-CC5C68CC05CBQ33852232-6FB1BCB6-7165-4549-91E8-B526AC955F9EQ33866067-EF3318B2-2303-45F7-8033-4FB85B8ED503Q33913070-1AF2C093-11FD-4407-AFB8-9DDBD897ADD3Q33914234-7F5D06F8-8AD4-4169-9462-A709000931A3Q33964167-A2E0D42D-AADB-4D76-8F52-BC0FC985B2CEQ34032032-9A5F266A-977F-4F4C-ADF8-A62A309123E0Q34037478-008695A2-DF16-49F2-900D-781FEF300923Q34038480-1F19EACD-5891-42F3-B061-88B0D2EF801CQ34090411-AE7ED07A-3E8D-4B89-B768-4C9506DBBD29Q34130424-66E9A851-2572-46F2-9AE8-14C1E449E01BQ34143913-F74CD3CB-BD67-4923-82EB-1057C2380683Q34174522-1063EBE3-71C8-4037-9DF3-12FA370EB0A4
P2860
New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
New model of tumor angiogenesi ...... ted by angiopoietins and VEGF.
@ast
New model of tumor angiogenesi ...... ted by angiopoietins and VEGF.
@en
type
label
New model of tumor angiogenesi ...... ted by angiopoietins and VEGF.
@ast
New model of tumor angiogenesi ...... ted by angiopoietins and VEGF.
@en
prefLabel
New model of tumor angiogenesi ...... ted by angiopoietins and VEGF.
@ast
New model of tumor angiogenesi ...... ted by angiopoietins and VEGF.
@en
P2093
P356
P1433
P1476
New model of tumor angiogenesi ...... ted by angiopoietins and VEGF.
@en
P2093
Wiegand SJ
Yancopoulos GD
P2888
P304
P356
10.1038/SJ.ONC.1203035
P407
P577
1999-09-01T00:00:00Z
P5875
P6179
1043078580